Concepedia

Veselin Valkov

VV

Statistics

Publications

4

Citations

839

H-Index

4

Active since

2016

Affiliations

University of Bern(Current)

St. Michael's Hospital

Cardialysis (Netherlands)

Veselin Valkov is an author at University of Bern specializing in cardiology, interventional cardiology, and antiplatelet therapy.

Publications per year

2016–2022

4

Publications

4

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 785 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial

Mariusz Tomaniak, Ply Chichareon, Rodrigo Modolo et al. · EuroIntervention · 2020 · 28 citations

Pharmacy, Cardiology, Pharmacotherapy +17

Serum levels of RIPK3 and troponin I as potential biomarkers for predicting impaired left ventricular function in patients with myocardial infarction with ST segment elevation and normal troponin I levels prior percutaneous coronary intervention

Ivan Donev, Jordanka G. Doneva, Veselin Valkov et al. · BioScience Trends · 2016 · 15 citations · Full text

Medicine, Cardiology, Clinical Cardiology +16

Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial

Felice Gragnano, Marcel Zwahlen, Pascal Vranckx et al. · Journal of the American Heart Association · 2022 · 11 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

1–4 of 4